Testsealabs Chlamydia Trachomatis Ag Test
Chlamydia trachomatis is the most common cause of sexually transmitted venereal infection worldwide. It consists of two forms: elementary bodies (the infectious form) and reticulate or inclusion bodies (the replicating form).
Chlamydia trachomatis has a high prevalence and asymptomatic carriage rate, with frequent serious complications in both women and neonates.
- In women, complications include cervicitis, urethritis, endometritis, pelvic inflammatory disease (PID), and an increased risk of ectopic pregnancy and infertility.
- Vertical transmission from mother to neonate during childbirth can cause inclusion conjunctivitis and pneumonia.
- In men, complications include urethritis and epididymitis. At least 40% of nongonococcal urethritis cases are associated with chlamydia infection.
Notably, approximately 70% of women with endocervical infections and up to 50% of men with urethral infections are asymptomatic.
Traditionally, chlamydia infection was diagnosed by detecting chlamydia inclusions in tissue culture cells. While culture is the most sensitive and specific laboratory method, it is labor-intensive, expensive, time-consuming (48–72 hours), and not routinely available in most institutions.
The Chlamydia Trachomatis Ag Test is a rapid qualitative test for detecting chlamydia antigen in clinical specimens, providing results in 15 minutes. It uses chlamydia-specific antibodies to selectively identify chlamydia antigen in clinical samples.





